As We Enter The Second Inning Of The Pandemic, Could This “Dark Horse” COVID Vaccine Stock Win The Long Game?

With the fast-spreading Delta variant of the coronavirus taking hold in the U.S. and many countries around the world, we may just be entering the second inning of the COVID-19 pandemic. As a result, when it comes to COVID-19 vaccine stocks, the author of today’s article argues that “For investors, the game is young, and there still remains many questions about who will emerge as the big winner(s) over time, because the current picture is just the first inning.” With that, they proceed to examine “some of the more interesting catalysts” for the more well-known vaccine stocks as well as “a dark horse candidate that could conceivably creep up and win it all in the later innings.” CLICK HERE.